JOSHUA HESS: Open Payments
NPI 1487140562 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 23 payments from 7 companies in 2025. Trend: 2023 $399 · 2024 $1,010 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $180 |
| Janssen Pharmaceuticals, Inc | 5 | $101 |
| Teva Pharmaceuticals USA, Inc. | 4 | $60 |
| Alkermes, Inc. | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: COBENFY, INVEGA SUSTENNA, ARISTADA, HETLIOZ, AUSTEDO XR, REXULTI, SPRAVATO, INGREZZA.
Industry payments across VA — which companies pay providers there.
